Matthew et al. transfected BACE1 siRNA into bioengineered exosomes, which specifically delivered BACE1 siRNA to neurons in the brain, significantly decreased the expression of BACE1 and attenuated AD [82]. This evidence concerns the gene BACE1 and Alzheimer disease.